Recombinant human TNF-α monoclonal antibody(SL Pharma/Combio)
重组全人源抗肿瘤坏死因子α单抗（双鹭药业/康明百奥）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human TNF-α monoclonal antibody(SL Pharma/Combio)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesBeijing Sl Pharmaceutical Co LtdBeijing Kangming Bio New Drug Development Co Ltd
China Registration ClassN/A
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A